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Introduction
The involvement of gut microbiota in type 2 diabetes has been recognized [1, 2] . Several Clostridium or lactobacilli species are reportedly enriched in type 2 diabetes [1, 2] . A study by Forslund et al, showed that gut microbes mediate the therapeutic effects of metformin through certain types of short-chain fatty acid production [3] . Gut microbiota may therefore influence insulin sensitivity. Serum metformin levels of type 2 diabetes patients are positively correlated with Escherichia abundance, whereas they are negative correlation with Intestinibacter abundance [3] .
Serotonin (5-hydroxytryptamine, 5-HT) is mainly synthesized, stored, and released from enterochromaffin cells within mucosal epithelia of the gut [4] . Gut microbes regulate 5-HT levels in the colon and blood. Spore-forming bacteria (Sp) from the mouse and human microbiota promote 5-HT biosynthesis from colonic enterochromaffin cells, which supply 5-HT to the mucosa, lumen, and circulating platelets [4] . The microbiota-dependent changes in gut 5-HT impact gastrointestinal motility and platelet function [4] . 5-HT1B and 5-HT4 receptors, which are distributed in the enteric nervous system and smooth muscle in the gut, may be involved in the gut-mediated glucose homeostasis [5, 6] . Pharmacologic stimulation of serotonin 5-HT1B or 5-HT4 receptors increases plasma active glucagon-like-peptide-1 levels independently of feeding and improves glucose tolerance under the dipeptidyl peptidase-4 inhibition in mice [5, 6] . Although it remains unclear whether gut microbiota influence insulin secretion, the gut microviota-5-HT axis may be a novel therapeutic target for type 2 diabetes in future.
